Filing Details
- Accession Number:
- 0001170362-14-000001
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-01-13 20:44:08
- Reporting Period:
- 2014-01-09
- Filing Date:
- 2014-01-13
- Accepted Time:
- 2014-01-13 20:44:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1080709 | Arena Pharmaceuticals Inc | ARNA | Pharmaceutical Preparations (2834) | 232908305 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1170362 | W Steven Spector | C/O Arena Pharmaceuticals, Inc. 6154 Nancy Ridge Drive San Diego CA 92121 | Evp, General Counsel & Sec | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-01-09 | 33,334 | $6.00 | 135,128 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-01-09 | 33,334 | $6.10 | 101,794 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2014-01-09 | 33,334 | $0.00 | 33,334 | $6.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2004-01-18 | 2014-01-18 | No | 4 | M | Direct |
Footnotes
- The amount includes shares purchased under Arena's employee stock purchase plan prior to the reported transaction.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The options were exercisable upon grant, but vested in four equal annual installments beginning on January 18, 2005.
Billionaire Hedge Funds
